Skip to main content
Journal of Neurodevelopmental Disorders logoLink to Journal of Neurodevelopmental Disorders
. 2017 Sep 13;9:34. doi: 10.1186/s11689-017-9214-9

EEG power at 3 months in infants at high familial risk for autism

April R Levin 1,2,3,✉,#, Kandice J Varcin 3,4,#, Heather M O’Leary 2, Helen Tager-Flusberg 5, Charles A Nelson 3,6
PMCID: PMC5598007  PMID: 28903722

Abstract

Background

Alterations in brain development during infancy may precede the behavioral manifestation of developmental disorders. Infants at increased risk for autism are also at increased risk for other developmental disorders, including, quite commonly, language disorders. Here we assess the extent to which electroencephalographic (EEG) differences in infants at high versus low familial risk for autism are present by 3 months of age, and elucidate the functional significance of EEG power at 3 months in predicting later development.

Methods

EEG data were acquired at 3 months in infant siblings of children with autism (high risk; n = 29) and infant siblings of typically developing children (low risk; n = 19) as part of a prospective, longitudinal investigation. Development across multiple domains was assessed at 6, 9, 12, 18, 24, and 36 months. Diagnosis of autism was determined at 18–36 months. We assessed relationships between 3-month-olds’ frontal EEG power and autism risk, autism outcome, language development, and development in other domains.

Results

Infants at high familial risk for autism had reduced frontal power at 3 months compared to infants at low familial risk for autism, across several frequency bands. Reduced frontal high-alpha power at 3 months was robustly associated with poorer expressive language at 12 months.

Conclusions

Reduced frontal power at 3 months may indicate increased risk for reduced expressive language skills at 12 months. This finding aligns with prior studies suggesting reduced power is a marker for atypical brain function, and infants at familial risk for autism are also at increased risk for altered developmental functioning in non-autism-specific domains.

Keywords: Autism, Electroencephalography, Early development, Infant siblings, Biomarker

Background

Autism spectrum disorder (ASD) is characterized by difficulties with social communication and the presence of restricted and repetitive behaviors or interests that emerge in the toddler years [1]. Infant siblings of children with ASD have a nearly 20% chance of developing ASD [2], a figure substantially higher than the estimated 1–2% prevalence in the general population [3]. This increased risk is not only specific to ASD, however. Among high-risk siblings who do not develop ASD, many demonstrate lower levels of verbal, nonverbal, and motor functioning than their low-risk counterparts [46].

Given increasing evidence for the efficacy of early intervention in improving developmental outcomes [7, 8], there is a need to delineate risk markers of atypical development to facilitate earlier intervention. Converging findings from prospective, longitudinal studies of high-risk infant siblings suggest that the first, overt behavioral signs of social communication delays associated with ASD do not manifest until late in the first year of life [9]. To assess even earlier risk signs for ASD and other developmental disorders, measuring the patterns of electrophysiological activity that ultimately determine or predict behavior offers significant promise. There is now accumulating evidence from electroencephalographic (EEG) studies suggesting that infants at high risk for ASD, regardless of whether they ultimately meet diagnostic criteria for ASD, have different developmental trajectories within the first year of life compared to low-risk infants [1020]. For example, at 6 months of age, high-risk infants show reduced frontal EEG power across all frequency bands compared to low-risk infants [20]. How early in life these differences manifest between high- and low-risk infant siblings, and how specific these findings are in predicting particular developmental disorders, remains to be delineated.

In the current study, our primary aim was to determine (1) whether differences in baseline frontal EEG power between high- and low-risk infants are present by 3 months of age. To date, early electrophysiological markers before 6 months have been scarcely explored. Our secondary aims were to elucidate the functional significance of differences in EEG power in early development. In particular, we aimed to determine (2) whether EEG power at 3 months distinguishes infants later diagnosed with ASD and (3) whether EEG power at 3 months predicts development in other domains (e.g., language), particularly over the first year of life.

Methods

Study design and participants

Participants in the current study were part of a prospective investigation examining infants at high versus low familial risk for ASD across the first 3 years of life. Infants were classified as high risk for autism (HRA) if they had at least one older sibling with a community diagnosis of ASD. When possible, ASD diagnoses in older siblings were verified using both the Autism Diagnostic Observation Schedule (ADOS) [21] and the Social Communication Questionnaire (SCQ) [22] (n = 14, 56% of the final, included sample) with best estimate clinical judgment by a psychologist, where required. Five older siblings (20%) had their community diagnosis verified using the SCQ only as they did not have an ADOS assessment. Four older siblings (16%) did not have SCQ data and instead had their diagnosis verified using the ADOS only. Two HRA older siblings (8%) did not have an SCQ or ADOS and as such were unable to have their community diagnosis verified, although both had received their diagnoses in specialist ASD clinics. Infants were classified as low-risk controls (LRC) if they had a typically developing older sibling and no first- or second-degree family members with ASD. When possible, older siblings of LRC infants were screened with the ADOS and the SCQ (n = 8; 57% of the final included sample) to ensure they did not meet criteria for ASD. One LRC proband (7%) did not have an ADOS assessment though they did not meet criteria on the SCQ. One other LRC proband (7%) did not have SCQ data though did not meet criteria for ASD on the ADOS. Four LRC older siblings (29%) did not have an SCQ or ADOS; however, data from the infant siblings were included as their parents reported no clinical concerns in the proband. Inclusion criteria for infants included a gestational age of at least 36 weeks, no known prenatal or postnatal complications and no known genetic disorder.

EEG recordings were collected from 29 HRA infants (18 male) and 19 LRC infants (13 male) at 3 months of age. Of these, 25 HRA infants (14 male) and 14 LRC infants (9 male) provided adequate EEG data for processing, as described below, and were therefore included for analysis.

Final ASD outcomes for infants who had 3-month EEG recordings was determined on the basis of the ADOS using the revised algorithm in convergence with clinical best estimate at the infant’s most recent visit (either at 18, 24, or 36 months). Of the 25 HRA infants with adequate EEG data, 7 met criteria for ASD (HRA+; all based on 36 month assessment outcomes), 15 were classified as no ASD (HRA−; n = 1 based on 24-month assessment outcomes and n = 14 based on 36-month assessment outcomes), and 3 had not completed outcome visits at either 18, 24, or 36 months due to their discontinuation in the study prior to 18 months. Of the 14 LRC infants, 8 completed an outcome assessment and none met criteria for ASD (LRC−; n = 2 based on 18-month assessment outcomes; n = 1 based on 24-month assessment outcomes; n = 5 based on 36-month assessment outcomes). Six LRC infants did not have outcome assessments due to study funding ending prior to these children reaching 18 months of age. The median ADOS-2 comparison score (a metric ranging from 1 to 10 that quantifies ASD symptomatology on the basis of raw ADOS scores, with higher values representing greater symptom severity) [23] for the LRC group was 1 (interquartile range 1) and 2 (interquartile range 2.25) for the HRA group. For the outcome groups, the median ADOS-2 comparison scores were as follows: LRC− = 1 (interquartile range 1), HRA− = 1 (interquartile range 1), and HRA+ = 5 (interquartile range 3).

Institutional review board approval was obtained from Boston University and Boston Children’s Hospital (# X06-08-0374) prior to starting the study. Written, informed consent was obtained from all caregivers prior to their children’s participation in the study.

Behavioral assessments

At 6, 12, 18, 24, and 36 months, infants were administered the Mullen Scales of Early Learning (MSEL) [24]. Age-standardized t scores were used to quantify development across five domains: gross motor (at 6 and 12 months only), fine motor, visual reception, expressive language, and receptive language.

The Autism Observation Scale for Infants (AOSI) [25] was administered at 9 and 12 months to quantify early markers associated with ASD. Higher scores indicate more atypical behaviors.

The ADOS was administered at 18, 24, and 36 months, along with clinical best estimate, to determine ASD diagnoses as described above.

EEG acquisition

Infant baseline EEG data were acquired in a dimly lit, sound-attenuated, electrically shielded room. The caregiver was seated in a chair holding their infant. Continuous EEG was recorded for between 2 and 5 min. (The initial protocol included 2 min of recording, but this was later increased to 5 min to ensure that the majority of infants would have adequate data for analysis after exclusion of artifact-contaminated epochs, as described below. The recording was truncated prior to completion in infants who became excessively fussy). A research assistant sat to the right of the caregiver and the infant. They were in the room for the recording to assist in keeping the infant calm and still by blowing bubbles or presenting a quiet toy to the infant if they became fussy (e.g., a ball).

EEG data were collected using either a 64-channel Geodesic Sensor Net System or a 128-channel Hydrocel Geodesic Sensor Net System and a Net Amps 200 amplifier or a Net Amps 300 high-input amplifier (Electrical Geodesics, Inc., Eugene, OR, USA). Both systems and net type were used across both risk groups. The majority of infants, however, had EEG recorded using 128-channel nets on a Net Amps 300 system (68% HRA; 86% LRC). Data were sampled at either 250 or 500 Hz and referenced to the vertex (electrode Cz), with impedances kept below 100 kΩ (within recommended guidelines given the high-input impedance capabilities of this system’s amplifier). Electrooculographic electrodes were removed to enhance infants’ tolerance of the net.

EEG pre-processing

Initial pre-processing of data took place in Net Station (EGI, Inc., Eugene, OR). A 1-Hz high-pass filter and a 60-Hz notch filter were applied. Any channel with excessive artifact in the majority of the recording (such that leaving that channel in the analysis would result in significantly more epoch exclusions, as described below, than interpolating that channel) and any channel that did not contain EEG data based on visual inspection of the signal (e.g., channels with flat tracings, or those in which low-frequency activity generally looked dissimilar to that of surrounding electrodes) were marked for interpolation. The number of interpolated channels did not exceed 10% of total active electrodes for any infant. Data were re-referenced to average after excluding marked channels (and later also transformed using a Laplacian reference, as described below). Data from all channels, including interpolated channels, was then exported to MATLAB (R2015a). In MATLAB, data sampled at 500 Hz were low pass filtered with a cutoff frequency of 100 Hz and downsampled to 250 Hz. Data were detrended using a Kalman filter [26] (b = 0.995) and epochs with high-amplitude artifact (> 150 μV) in any channel were excluded from further analysis. Remaining segments of useable data were then further segmented into one-second, non-overlapping segments. Infants with fewer than 10 good segments were excluded from further analyses.

All analyses were initially run with average referencing and then repeated with a Laplacian reference, as Laplacian referencing has been shown to reduce sensitivity of the EEG signal to contamination by myogenic activity, particularly in central regions but also in frontal and occipital regions [27]. Laplacian referencing involves referencing the activity in each electrode to that of its nearest neighbors, thus enhancing sensitivity to local activity and reducing sensitivity to more diffuse or volume-conducted activity.

EEG power analysis

A fast Fourier transform with a Hanning window was used to calculate a power spectrum on each segment. For each EEG, the average power spectrum across all one-second segments was then calculated. As our primary aim involved determining if differences in frontal EEG power previously reported among high-risk infants at 6 months [20] extend to earlier in life (i.e., at 3 months), our primary region of interest was over the frontal region. We replicated a previously described frontal region of interest, [20] centered on electrodes F3 and F4. In the 64-channel net, this frontal region included channels 3, 8, 9, 13 (F3), 16, 57, 58, and 62 (F4); in the 128-channel net, it included channels 3, 4, 10, 18, 19, 20, 23, 24 (F3), 27, 118, 123, and 124 (F4). Because the Laplacian-referenced data was calculated only on electrodes in the 10–20 electrode reference system (using surrounding electrodes in the high-density array as the reference electrodes), the frontal region for the Laplacian reference included channels F3 and F4. A spectral slope between 20 and 200 Hz of greater than − 0.1 has previously been used to suggest significant contribution from muscle artifact [28], since the EEG power spectrum from brain activity generally fits a 1/(f α) (“pink noise”) structure. Because our analyses evaluated power only up to 50 Hz, and because our sampling rates would result in 200 Hz being well above the Nyquist frequency for many of the EEGs included in this analysis, we measured slope of the power spectrum between 20 and 50 Hz. These measurements were conducted on a log-log plot by using the MATLAB polyfit function.

Statistical analyses

Results are presented two ways: Binned by frequency band, and unbinned. Binned power is more standard in the developmental literature and allows for assessment of oscillatory activity that rises above background activity [29]. However, recent evidence suggests that the background activity itself (i.e., the “shape” of the power spectrum) also contains crucial information about underlying electrophysiology [30, 31]. Unbinned power allows assessment of overall trends in this background activity.

For analysis of binned data, frequency bands were defined as previously described (delta [2–4 Hz], theta [4–6 Hz], low alpha [6–9 Hz], high alpha [9–13 Hz], beta [13–30 Hz], gamma [30–50 Hz]) [20]. Here we report all binned data as absolute power values, normalized by a log 10 transform. Behavioral data and EEG data in some frequency bands were non-normal (based on a Shapiro-Wilk, p < .05 and histogram observation). As such, Mann-Whitney U nonparametric tests were performed to compare binned power values and performance on behavioral tasks between HRA and LRC groups. A Kruskal-Wallis one-way analysis of variance was performed to compare binned power values between ASD outcome groups (LRC−, HRA+, HRA−). Spearman’s rho correlations were performed to examine associations between binned frontal power values at 3 months with developmental functioning on the MSEL and AOSI. In this regard, we primarily focused on the association between 3-month frontal EEG power and developmental functioning on the MSEL and AOSI over the first year of life (i.e., at 6–12 months). However, in order to examine the persistence (or transience) of any significant associations over the first year, we then conducted a separate set of analyses focused on the association between 3-month frontal EEG power and MSEL scores over the second and third years of life (i.e., at 18, 24, and 36 months). Of note, power to detect such associations on the MSEL was higher in the first year of life due to a decline in sample size at later ages (6 months: n = 36; 12 months: n = 36; 18 months: n = 30; 24 months: n = 28; 36 months: n = 26). A false discovery rate (FDR) correction at p < .05 was applied to the p values from nonparametric tests to control for multiple comparisons [32]. For binned power analyses, the FDR correction was applied separately to average reference power data and Laplacian-transformed data, and to analyses focused on 6–12- and 18–36-month outcomes. All reports of significance for binned data are with reference to those effects that remained significant after FDR correction. All of the abovementioned analyses were conducted using SPSS version 23.0 (IBM Corp, Armonk, NY).

For analysis of unbinned data, we computed the median and 25th–75th percentile at each point of the power spectrum within each group, as well as the median difference in group-averaged power spectra by using a frequency domain-based bootstrapping algorithm with 2000 replications, as previously described, [33, 34] using publicly available MATLAB code [33]. Because these analyses in their current form can only be used to compare outcomes between two groups, analyses of unbinned data were restricted to HRA versus LRC, and HRA+ versus HRA−.

Results

Of note, the final LRC and HRA samples did not differ significantly in their gender distribution (X 2 = .26, df = 1, p = .614 [LRC: n = 5/14, 36% female; HRA: n = 11/25, 44% female] or age at the time of their EEG recording (t(35) = 1.71, p = .097 [LRC mean age = 3.68 months, SD = .44; HRA mean age = 3.41 months, SD = .49]).

Behavioral assessments

Mullen Scales of Early Learning

Risk group (HRA/LRC) comparison

6 and 12 months: At 6 months of age, there was a trend toward significantly lower gross motor scores in the HRA group compared to the LRC group (Table 1), U = 87.50, z = − 1.925, p = .057. There were no differences between risk groups in any other subdomains (all p values > .05). At 12 months, the HRA group revealed a trend toward lower gross motor scores, U = 94.00, z = −1.801, p = .077, and significantly lower scores in the expressive language domain, U = 65.50, z = − 2.913, p = .003. There were no group differences in visual reception, fine motor, or receptive language skills at 12 months (all p values > .05). Median subscale scores (and interquartile ranges) for each risk group are presented in Table 1.

Table 1.

Risk group (HRA, LRC) developmental functioning scores at 6, 9, 12, 18, 24, and 36 months

Risk groups
6 months 9 months 12 months 18 months 24 months 36 months
HRA (n = 22) LRC (n = 14) HRA (n = 14) LRC (n = 11) HRA (n = 22) LRC (n = 14) HRA (n = 21) LRC (n = 9) HRA (n = 22) LRC (n = 6) HRA (n = 21) LRC (n = 5)
Gross motor 46 (13) 53 (12) 43 (20) 48 (23)
Fine motor 46 (12) 46 (9) 60 (21) 60 (12) 54 (10) 49 (14) 48 (8) 50 (17) 45 (15) 55 (33)
Visual reception 45 (13) 45 (19) 54 (11) 58 (10) 48 (7) 56 (10) 49 (10) 56 (13) 58 (23) 58 (24)
Expressive language 45 (8) 45 (6) 46 (10) 57 (7) 51 (13) 54 (7) 54 (17) 58 (8) 56 (14) 56 (16)
Receptive language 47 (9) 44 (2) 44 (10) 44 (5) 55 (30) 69 (11) 53 (8) 64 (10) 54 (12) 58 (17)
AOSI total 4 (5) 5 (4) 3 (3)a 3 (5)b

Median scores (and interquartile range) on developmental assessments for infants with EEG data at 3 months

aOne HRA infant was missing AOSI data at 12 months

b6 LRC infants were missing AOSI data at 12 months

18, 24, and 36 months: At 18 months, the HRA group had significantly lower visual reception, U = 40.00, z = −2.501, p = .012, and receptive language scores, U = 33.00, z = − 2.798, p = .004 compared to the LRC group. These differences persisted at 24 months, with the HRA group demonstrating significantly lower visual reception scores, U = 25.50, z = − 2.292, p = .020, and receptive language scores, U = 20.00, z = − 2.594, p = .008, compared to the LRC group. There were no group differences in any other subdomains at 18 or 24 months. There were no group differences in any subscale at 36 months (all p values > .05). Median subscale scores (and interquartile ranges) are presented in Table 1.

Outcome group (HRA+/HRA−/LRC−) comparison

6 and 12 months: A Kruskal-Wallis H test found no significant differences between outcome groups on any subscales of the Mullen at 6 months of age (all p values > .05). At 12 months, however, there were significant group differences in the receptive language (H(2) = 9.87, p = .007) and expressive language (H(2) = 9.59, p = .008) subscales. Follow-up pairwise comparisons showed that the HRA+ group at 12 months had significantly lower receptive language scores compared to the HRA− group (p = .005) and significantly lower expressive language scores compared to the LRC− group (p = .006). There were no group differences in visual reception or fine motor skills at 12 months (all p values > .05). Median subscale scores (and interquartile ranges) for each outcome group are presented in Table 2.

Table 2.

Outcome group (HRA+, HRA−, LRC−) developmental functioning scores at 6, 9, 12, 18, 24, and 36 months

Outcome groups
6 months 9 months 12 months 18 months 24 months 36 months
HRA+ (n = 7) HRA− (n = 14) LRC− (n = 8) HRA+ (n = 6) HRA− (n = 11) LRC− (n = 5) HRA+ (n = 7) HRA− (n = 14) LRC− (n = 8) HRA+ (n = 6) HRA− (n = 15) LRC− (n = 8) HRA+ (n = 7) HRA− (n = 15) LRC− (n = 6) HRA+ (n = 7) HRA− (n = 14) LRC− (n = 5)
Gross motor 40 (13) 47 (9) 53 (10) 43 (17) 40 (23) 48 (20)
Fine motor 46 (12) 46 (14) 46 (6) 55 (19) 62.5 (16) 57.5 (15) 53 (6) 54 (14) 52 (17) 48 (10) 48 (8) 50 (17) 39 (17) 50 (14) 55 (33)
Visual reception 45 (7) 45 (19) 45 (18) 49 (9) 57 (9) 60 (8) 48 (18) 48 (6) 56 (11) 49 (9) 53 (10) 56 (13) 52 (25) 59 (23) 58 (24)
Expressive language 48 (6) 42 (8) 48 (6) 37 (8) 46 (9) 54 (6) 42 (17) 51 (10) 54 (9) 41 (28) 56 (15) 58 (8) 49 (16) 57 (11) 56 (16)
Receptive language 44 (6) 47 (19) 44 (0) 37.5 (11) 44 (6) 44 (5) 33 (33) 59 (22) 70 (8) 50 (26) 56 (7) 64 (10) 49 (7) 56 (9) 58 (17)
AOSI total 3 (5) 4 (6) 3 (5) 4 (3) 2.5 (3) 1.5 (3)

Median scores (and interquartile range) on developmental assessments for infants with EEG data at 3 months

18, 24, and 36 months: A Kruskal-Wallis H test found significant differences between outcome groups at both 18 and 24 months. Specifically, at 18 months, there were significant differences in the visual reception (H(2) = 6.47, p = .039), receptive language (H(2) = 12.55, p = .002), and expressive language (H(2) = 6.26, p = .044) subscales. Follow-up pairwise comparisons showed that for the visual reception and expressive language subscales, there was a trend for the HRA+ group to have the lowest scores; however, no comparisons reached significance. For the receptive language subscale, follow-up pairwise comparisons showed that both the HRA+ and the HRA− groups had significantly lower scores compared to the LRC− group at 18 months (p = .002 and p = .041, respectively). At 24 months, there were significant differences in the visual reception (H(2) = 6.41, p = .041) and receptive language (H(2) = 14.54, p = .001) subscales. For the visual reception subscale, follow-up pairwise comparisons showed that the HRA+ group had significantly lower scores compared to the LRC− group at 24 months (p = .037). For the receptive language subscale, the HRA+ group had lower scores than both the HRA− group (p = .016) and the LRC− group (p = .001). There were no outcome group differences in any subscale at 36 months (all p values > .05). Median scores are presented in Table 2.

Autism Observation Scale for Infants

Of note, only a subset of the sample had AOSI data available at 9 and 12 months (9 months: 56% of the HRA group, 70% of the LRC group; 12 months: 84% of the HRA group, 57% of the LRC sample).

Risk group (HRA/LRC) comparison

There were no significant differences in total scores between HRA and LRC infants at 9 months on the AOSI (U = 101.50, z = − .130, p = .899) or 12 months (U = 165.50, z = .377, p = .713). Medians and interquartile ranges for the total scores at 9 and 12 months (for the final, included sample of infants with good EEG data) are reported in Table 1.

Outcome group (HRA+/HRA−/LRC−) comparison

There were no significant differences in total scores between the outcome groups on the AOSI at 9 months (H(2) = .33, p = .849) or 12 months (H(2) = 4.18, p = .123). Medians and interquartile ranges are reported by outcome group in Table 2.

EEG data quality

There were no differences in power as a function of net and amplifier type within any frequency band, in either the average referenced data (consistent with findings from Tierney et al.) or Laplacian-transformed data; all p values > .05. As such, all further analyses were conducted with EEG data collapsed across acquisition setups. There were no significant group differences in the number of interpolated channels between the HRA (median = 2 channels) and the LRC (median = 2 channels) groups, U = 183.50, z = .256, p = .806, or between LRC− (median = 1.5 channels), HRA− (median = 2 channels), and HRA+ (median = 1 channel) infants, H(2) = 3.53, p = .171. The median number of good segments did not significantly differ between the HRA (median = 73) and the LRC (median = 57.5) groups, U = 206.50, z = .922, p = .361. There were also no significant differences in the number of good segments between LRC− (median = 79), HRA− (median = 60), and HRA+ (median = 70), H(2) = .114, p = .945). We also calculated the proportion of data retained (versus rejected) after artifact detection as a function of the total EEG recording length. The proportion of good data within each recording did not significantly differ between HRA (median 45.34%) and LRC groups (median 41.95%), U = 209.00, z = .995, p = .331, or LRC− (median: 50.18%), HRA− (45.34%), and HRA+ (43.19%) groups, H(2) = .261, p = .877. Spectral slope met the aforementioned criteria of being <− 0.1 for all groups, across all channels standardly included in a 10–20 system.

Power spectral density at 3 months by ASD risk status: HRA versus LRC

Average reference, binned analyses: In the binned average-referenced data, the HRA group had significantly lower power over the frontal region in the high-alpha band (U = 71.00, z = −3.045, p = .002, r = .49) and beta band (U = 70.00, z = −3.074, p = .002, r = .49) after the FDR correction (Fig. 1a). There were no significant group differences in any other frequency band over the frontal region.

Fig. 1.

Fig. 1

3-month frontal EEG power by risk group. a, b Frontal binned power spectral density (log10 transformed) at 3 months of age for LRC and HRA risk groups for each frequency band, using a average-referenced data and b Laplacian-referenced data. Asterisks (*) denote significant results after FDR correction. c Frontal unbinned group-median power spectra (solid line, median; shaded area, 25th–75th percentile) showing EEG power at 3 months of age across all frequencies in HRA and LRC groups, for average-referenced data. (Pink line, HRA; cyan line, LRC). d Differences in frontal unbinned group-median power spectra at 3 months of age, presented with 95% CI from the bootstrap analysis (average-referenced data) (purple line, 2.5th percentile; orange line, 97.5th percentile). EEG power is similar across all frequencies for the HRA as compared to the LRC group. e, f Same analysis as (c, d), for Laplacian-referenced data. A significant decrease in frontal power in the HRA group compared to the LRC group emerges above approximately 20 Hz. LRC = low-risk control; HRA = high-risk for autism

Average reference, unbinned analyses: In the unbinned average-referenced data, there were no significant differences in group-averaged frontal (Fig. 1c, d) power spectra between HRA and LRC groups.

Laplacian reference, binned analyses: In the binned Laplacian-referenced data, there were no significant differences between HRA and LRC groups in any frequency band over the frontal (Fig. 1b) region.

Laplacian reference, unbinned analyses: In the unbinned Laplacian-referenced data, the HRA group had significantly lower power over the frontal region in all frequencies greater than 20 Hz, as compared to the LRC group (Fig. 1e, f).

Power spectral density at 3 months by ASD outcome: LRC−, HRA−, and HRA+

Topoplots demonstrating the distribution of power across the scalp in each frequency band are provided in Fig. 2.

Fig. 2.

Fig. 2

Topoplots demonstrating the scalp distribution of EEG power for a average-referenced and b Laplacian-referenced data. Rim electrodes not shown. For each frequency band, plots represent average power for HRA+, HRA−, or LRC− groups. Color bars represent log10 transformed power

Average reference, binned analyses: We conducted a Kruskal-Wallis H test to examine differences in power between outcome groups (LRC−, HRA−, HRA+). While binned analyses for the average-referenced data revealed a pattern of lower frontal power through higher frequency bands (high-alpha, beta, gamma) among HRA+ infants, no effects reached statistical significance in our sample (Fig. 3a).

Fig. 3.

Fig. 3

3-month frontal EEG power by outcome group. a, b Frontal binned power spectral density (log10 transformed) at 3 months of age for LRC−, HRA−, and HRA+ outcome groups for each frequency band, using a average-referenced data and b Laplacian-referenced data. c Frontal unbinned group-median power spectra (solid line, median; shaded area, 25th–75th percentile) showing EEG power at 3 months of age across all frequencies in HRA+ and HRA− groups, for average-referenced data. (Red line, HRA+; green line, HRA−). d Differences in frontal unbinned group-median power spectra at 3 months of age, presented with 95% CI from the bootstrap analysis (average-referenced data) (purple line, 2.5th percentile; orange line, 97.5th percentile). EEG power is similar across all frequencies for the HRA+ as compared to the HRA− group. e, f Same analysis as (c, d), for Laplacian-referenced data. There are no significant differences in power in the HRA+ group compared to the HRA− group at any frequency. LRC− = low-risk control, no ASD; HRA− = high-risk for autism, no ASD; HRA+ = high-risk for autism, with ASD

Average reference, unbinned analyses: Unbinned analyses for average referenced data revealed no significant differences across the power spectrum in HRA+ infants as compared to HRA− infants (Fig. 3c, d).

Laplacian reference, binned analyses: There were no significant differences as a function of outcome group in any frequency band for Laplacian-referenced power data (all p values > .05) (Fig. 3b).

Laplacian reference, unbinned analyses: Unbinned analyses for Laplacian-referenced data revealed no significant differences across the power spectrum in HRA+ infants as compared to HRA− infants (Fig. 3e, f).

Correlations between 3-month frontal EEG power and developmental functioning

Autism Observation Scale for Infants

There were no significant correlations between EEG power at 3 months (in either average-referenced data or Laplacian transformed) and AOSI total scores at either 9 or 12 months (all p values > .05).

Mullen Scales of Early Learning

6 and 12 months: For the average-referenced power data, there was a positive correlation between 3-month frontal high-alpha power and expressive language level at 12 months (r s = .463, N = 36, p = .004) that survived FDR correction (Fig. 4). No other correlations between 3-month frontal EEG power and developmental functioning, on any subscale, survived correction for multiple comparisons. For the Laplacian-transformed power, there were no significant correlations between 3-month frontal power and developmental functioning either prior, or subsequent, to FDR correction (all p values > .05).

Fig. 4.

Fig. 4

Spearman’s rho correlations (with fitted line) between 3-month frontal power (log10 transformed) in the high-alpha (9–13 Hz) band and T scores on the MSEL expressive language subscale for LRC (cyan circles) and HRA (pink squares) infants

18, 24, and 36 months: There were no significant correlations between 3-month frontal EEG power and scores on the MSEL subscales that survived FDR correction at 18, 24, or 36 months for either the average-referenced power or Laplacian-transformed power.

Discussion

The findings reported here reveal that 3-month-old infants at high familial risk for ASD have reduced frontal high alpha and beta power (in an average-referenced, binned analysis) and reduced frontal power in frequencies above 20 Hz (in a Laplacian-referenced, unbinned analysis) compared to same-aged infants at low familial risk for ASD. Reduced frontal power did not predict ASD-specific outcomes; however, reduced frontal high-alpha power at 3 months was associated with reduced expressive language skills at 12 months.

A key finding here is the early age (3 months) at which EEG findings correlate with risk status, and with later developmental outcomes. To our knowledge, while decreased EEG power in young children has been previously associated with increased risk for social and communication difficulties [20, 35], no study has previously evaluated the association between EEG power and developmental risk or outcome in infants younger than 6 months. Our findings are consistent with prior studies suggesting that physiologic changes may be detectable before behavioral changes become manifest in a variety of neurological and neurodevelopmental disorders [3643].

Notably, the association between 3-month frontal high-alpha power and expressive language skills appeared to be developmentally time-locked to the 12-month time point, with no evidence of this association persisting over the second and third years of life in our sample. This can be interpreted in one of two ways. First, 3-month power may portend only a transient decrease in expressive language skills, which resolves by 18–36 months of age. Alternatively, it is important to note that the sample size for participants who underwent MSEL testing decreases from 1 to 3 years of age in our study. Therefore, it is worth considering the possibility that a larger sample size at 18-, 24-, and 36-month time points would have been better powered to identify any persistent correlations between 3-month frontal high-alpha power and later expressive language skills.

A second key finding is that reduced EEG power at 3 months correlates most robustly with familial ASD risk and at least a transient change in expressive language development, rather than ASD outcomes specifically. This is consistent with studies suggesting that infants carrying a familial high-risk ASD endophenotype can present with altered development in multiple domains [4, 6]. Thus while ASD and language delay are considered to be discrete (albeit frequently overlapping) clinical entities, the physiology (as measured by EEG) is consistent with prior studies suggesting that the underlying risk factors for these disorders may overlap [44]. For example, alpha oscillations have been associated with temporal integration [45, 46], attentional control of speech processing [47], and verbal fluency [48]. Frontal alpha power may thus predict later expressive language by altering an infant’s ability to attend to, integrate, and ultimately produce speech; however, it may also affect an infant’s ability to attend to and integrate nonverbal stimuli as well.

While these associations are noteworthy, we cannot delineate the physiologic mechanisms underlying low frontal EEG power in high-risk infants from these findings alone. This is an important avenue for future research. In particular, contributions of muscle activity are difficult to quantify in infants, and the awake infant EEG signal will include a combination of information about underlying brain activity and muscle or other artifact. We took numerous steps to limit the impact of such artifact on our data, including the use of the Laplacian reference, [27] conservative artifact removal in which epochs with even one channel with high-amplitude artifact were removed from further analysis, verification that the slope of the power spectra was always <− 0.1, consistent with brain activity more so than muscle activity [28], and verification that measures of EEG data quality did not differ between groups. While these steps serve to enhance the signal to noise ratio of the EEG, we maintain that the contribution of muscle and other artifact cannot be entirely disentangled and, as such, the findings should be considered in this context.

The different findings seen across referencing types also merit further discussion here, because the sum of these complementary analyses provides a more nuanced picture of brain function than any single analysis alone. First, presenting analyses using both average referencing and Laplacian referencing allows for more targeted analysis of widespread versus localized activity. Our results demonstrate that the increased activity in high-alpha and beta in the HRA group (compared to LRC) and the correlation between high-alpha and expressive language are only present in the average-referenced binned analyses; they are not present in the Laplacian-referenced binned analyses. By referencing the EEG tracing at a given electrode to that of its nearest neighbors, the Laplacian reference mitigates the effect of diffuse activity sensed by multiple electrodes (including volume-conducted artifact but also widespread neural activity) and improves sensitivity to local activity. One possibility is therefore that our average-referenced findings are due to volume-conducted artifact and thus removed by the Laplacian reference. Alternatively, it remains quite possible that the relevant high-alpha oscillations are true neural activity, but are diffuse rather than localized, and are therefore removed by Laplacian referencing.

Additionally, binned and unbinned analyses provide complementary information. While binned analyses allow for assessment of oscillatory activity that rises above background activity [29], recent evidence suggests that the shape of the power spectrum, best measured by unbinned analyses, also contains highly relevant information about underlying physiology. Our unbinned Laplacian analyses suggest that the shape of the power spectrum is different between HRA and LRC groups, with the HRA group displaying decreased power above 20 Hz. This decreased power in higher frequencies can be seen when muscle activity is decreased (as above), but also when spontaneous background neuronal firing activity is decreased [30, 31]. This activity can be altered by abnormal baseline neuronal function (e.g., if neurons in HRA infants are too “passive” without adequate spontaneous neural activity). It has been hypothesized, for example, that spontaneous background neural “noise” is necessary to prevent excessive local overcoupling [31]. However, such activity can also be altered by behavioral or cognitive state. Therefore, one cannot rule out the possibility that differences in EEG power may be due to differences in infant state or behavior during data acquisition. Notably, however, these two possibilities (altered neuronal function and altered state) are not mutually exclusive; in fact, they are highly interrelated. Specifically, if background neuronal activity is altered in the HRA group, this may also alter the infant’s tendency toward a particular behavioral state during the baseline EEG collection paradigm.

Taken in combination with other studies evaluating brain rhythms in high-risk and low-risk groups at different times during development, the findings described here emphasize the dynamic nature of development. At 3 months, we see reduced average-referenced, binned frontal power in high-risk infants only in the high alpha and beta bands, whereas a prior study suggested that by 6 months, this pattern is seen across all frequency bands [20]. Of course, caution should be exercised in comparing findings across studies, given differences in processing techniques. (For example, in order to avoid concatenation of epochs otherwise interrupted by artifact, as this can introduce spurious findings at the boundaries between epochs, detrending and windowing settings in the current study are from those described in Tierney et al.). Even so, the possibility that diffuse low power in the high alpha and beta bands could portend developmental profiles of atypical oscillations in other frequency bands over the next several months is interesting to consider, particularly in the context of other studies suggesting altered trajectories of functional connectivity in high risk infants [17, 49]. Future studies examining trajectory of neural rhythms over time in high-risk and low-risk groups, beginning in early infancy and including large sample sizes into the third year of life and beyond, will be of tremendous benefit in improving our understanding of such trajectories and their implications.

Conclusions

Overall, the findings described here suggest that frontal EEG power at 3 months of age differs in infants at high versus low risk for ASD, and correlates with development of expressive language skills at 12 months of age. This work aligns with an emerging body of evidence demonstrating changes in brain development prior to the manifestation of overt behavioral changes in infants at high familial risk for ASD [39, 42, 43], and points to the potential of brain-based markers for early identification and prognostication in neurodevelopmental disorders. Future studies will offer the opportunity to elucidate the mechanisms underlying this finding, to better characterize the long-term trajectories of brain development that underlie behavior, and to determine potential clinical implications of these findings.

Acknowledgements

We thank the many dedicated families and staff who have been involved in this work since the project was first implemented.

Funding

Support for this work was provided by the National Institutes of Health (R01-DC010290 to HTF and CAN; R21 DC 08637 to HTF), Autism Speaks (1323 to HTF), Simons Foundation (137186 to CAN), the American Brain Foundation (to ARL), Autism Science Foundation (to ARL), Nancy Lurie Marks Family Foundation (to ARL), and the American Australian Association (to KJV). The funding bodies did not have any role in the design, collection, analyses, and interpretation of data or in writing the manuscript.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

ADOS

Autism Diagnostic Observation Schedule

AOSI

Autism Observation Scale for Infants

ASD

Autism spectrum disorder

EEG

Electroencephalography/electroencephalographic

FDR

False discovery rate

HRA

High risk for autism

HRA-

High-risk infants without autism

HRA+ 

High-risk infants with autism

LRC

Low-risk controls

LRC-

Low-risk controls without autism

MSEL

Mullen Scales of Early Learning

SCQ

Social Communication Questionnaire

Authors’ contributions

ARL and KJV contributed equally to the study conception, analysis and interpretation of data and drafting of the manuscript. ARL and HMO prepared the EEG data. KJV was involved in the acquisition of the EEG and behavioral data. HMO critically revised the manuscript for important intellectual content. HTF and CAN were responsible for the study design, overseeing the acquisition of data, and made substantial contributions to the interpretation of data, and critically revised the manuscript for important intellectual content. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Institutional review board approval was obtained from Boston University and Boston Children’s Hospital (#X06-08-0374) prior to starting the study. Written, informed consent was obtained from all caregivers prior to their children’s participation in the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

April R. Levin, Phone: +1 (857) 218 3786, Email: april.levin@childrens.harvard.edu

Kandice J. Varcin, Email: Kandice.varcin@telethonkids.org.au

Heather M. O’Leary, Email: heather.oleary@childrens.harvard.edu

Helen Tager-Flusberg, Email: htagerf@bu.edu.

Charles A. Nelson, Email: Charles_nelson@harvard.edu

References

  • 1.American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5. Arlington: American Psychiatric Publishing, Inc.; 2013. [Google Scholar]
  • 2.Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, Zwaigenbaum L, et al. Recurrence risk for autism spectrum disorders: a baby siblings research consortium study. Pediatrics. 2011;128:e488–e495. doi: 10.1542/peds.2010-2825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.CDC. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ. 2014;63:1-21. [PubMed]
  • 4.Messinger D, Young GS, Ozonoff S, Dobkins K, Carter A, Zwaigenbaum L, et al. Beyond autism: a baby siblings research consortium study of high-risk children at three years of age. J Am Acad Child Adolesc Psychiatry. 2013;52:300–8.e1 [DOI] [PMC free article] [PubMed]
  • 5.Leonard HC, Bedford R, Charman T, Elsabbagh M, Johnson MH, Hill EL, et al. Motor development in children at risk of autism: a follow-up study of infant siblings. Autism. 2014;18:281–291. doi: 10.1177/1362361312470037. [DOI] [PubMed] [Google Scholar]
  • 6.Charman T, Young GS, Brian J, Carter A, Carver LJ, Chawarska K, et al. Non-ASD outcomes at 36 months in siblings at familial risk for autism spectrum disorder (ASD): a baby siblings research consortium (BSRC) study. Autism Res. 2016;10:169–178. [DOI] [PMC free article] [PubMed]
  • 7.Estes A, Munson J, Rogers SJ, Greenson J, Winter J, Dawson G. Long-term outcomes of early intervention in 6-year-old children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2015;54:580–7. [DOI] [PMC free article] [PubMed]
  • 8.Zwaigenbaum L, Bauman ML, Choueiri R, Kasari C, Carter A, Granpeesheh D, et al. Early intervention for children with autism spectrum disorder under 3 years of age: recommendations for practice and research. Pediatrics. 2015;136:S60–S81. doi: 10.1542/peds.2014-3667E. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jones EJH, Gliga T, Bedford R, Charman T, Johnson MH. Developmental pathways to autism: a review of prospective studies of infants at risk. Neurosci Biobehav Rev. 2014;39:1–33. [DOI] [PMC free article] [PubMed]
  • 10.Bosl W, Tierney A, Tager-Flusberg H, Nelson C. EEG complexity as a biomarker for autism spectrum disorder risk. BMC Med. 2011;9:18. [DOI] [PMC free article] [PubMed]
  • 11.Elsabbagh M, Johnson MH. Getting answers from babies about autism. Trends Cogn Sci. 2010;14:81–87. doi: 10.1016/j.tics.2009.12.005. [DOI] [PubMed] [Google Scholar]
  • 12.Gabard-Durnam L, Tierney AL, Vogel-Farley V, Tager-Flusberg H, Nelson CA. Alpha asymmetry in infants at risk for autism spectrum disorders. J Autism Dev Disord. 2015;45:473–480. doi: 10.1007/s10803-013-1926-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Guiraud JA, Kushnerenko E, Tomalski P, Davies K, Ribeiro H, Johnson MH. Differential habituation to repeated sounds in infants at high risk for autism. Neuroreport. 2011;22:845–849. doi: 10.1097/WNR.0b013e32834c0bec. [DOI] [PubMed] [Google Scholar]
  • 14.Keehn B, Vogel-Farley V, Tager-Flusberg H, Nelson CA. Atypical hemispheric specialization for faces in infants at risk for autism spectrum disorder. Autism Res. 2015;8:187–198. doi: 10.1002/aur.1438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Key APF, Stone WL. Same but different: 9-month-old infants at average and high risk for autism look at the same facial features but process them using different brain mechanisms. Autism Res. 2012;5:253–266. doi: 10.1002/aur.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.McCleery JP, Akshoomoff N, Dobkins KR, Carver LJ. Atypical face versus object processing and hemispheric asymmetries in 10-month-old infants at risk for autism. Biol Psychiatry. 2009;66:950–7. [DOI] [PMC free article] [PubMed]
  • 17.Righi G, Tierney AL, Tager-Flusberg H, Nelson CA. Functional connectivity in the first year of life in infants at risk for autism spectrum disorder: an EEG study. PLoS One. 2014;9:e105176. [DOI] [PMC free article] [PubMed]
  • 18.Seery AM, Vogel-Farley V, Tager-Flusberg H, Nelson CA. Atypical lateralization of ERP response to native and non-native speech in infants at risk for autism spectrum disorder. Dev Cogn Neurosci. 2013;5:10–24. doi: 10.1016/j.dcn.2012.11.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Seery A, Tager-Flusberg H, Nelson CA. Event-related potentials to repeated speech in 9-month-old infants at risk for autism spectrum disorder. J Neurodev Disord. 2014;6:43. doi: 10.1186/1866-1955-6-43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Tierney AL, Gabard-Durnam L, Vogel-Farley V, Tager-Flusberg H, Nelson CA. Developmental trajectories of resting eeg power: an endophenotype of autism spectrum disorder. PLoS One. 2012;7:e39127. [DOI] [PMC free article] [PubMed]
  • 21.Lord C, Rutter M, DiLavore PC, Risi S. Autism diagnostic observation schedule (ADOS) Los Angeles: Western Psychological Services; 2001. [Google Scholar]
  • 22.Rutter M, Bailey A, Lord C. The social communication questionnaire manual. Western Psychological Services. 2003. [Google Scholar]
  • 23.Gotham K, Pickles A, Lord C. Standardizing ADOS scores for a measure of severity in autism spectrum disorders. J Autism Dev Disord. 2009;39:693–705. doi: 10.1007/s10803-008-0674-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Mullen EM. Mullen Scales of Early Learning: AGS Edition. Circle Pines: American Guidance Service; 1995. [Google Scholar]
  • 25.Bryson SE, Zwaigenbaum L, McDermott C, Rombough V, Brian J. The autism observation scale for infants: scale development and reliability data. J Autism Dev Disord. 2008;38:731–738. doi: 10.1007/s10803-007-0440-y. [DOI] [PubMed] [Google Scholar]
  • 26.Morbidi F, Garulli A, Prattichizzo D, Rizzo C, Rossi S. Application of Kalman filter to remove TMS-induced artifacts from EEG recordings. IEEE Trans Control Syst Technol. 2008;16:1360–1366. doi: 10.1109/TCST.2008.921814. [DOI] [Google Scholar]
  • 27.Fitzgibbon SP, Lewis TW, Powers DMW, Whitham EW, Willoughby JO, Pope KJ. Surface laplacian of central scalp electrical signals is insensitive to muscle contamination. IEEE Trans Biomed Eng. 2013;60:4–9. doi: 10.1109/TBME.2012.2195662. [DOI] [PubMed] [Google Scholar]
  • 28.Isler JR, Tarullo AR, Grieve PG, Housman E, Kaku M, Stark RI, et al. Toward an electrocortical biomarker of cognition for newborn infants. Dev Sci. 2012;15:260–271. doi: 10.1111/j.1467-7687.2011.01122.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Lopes da Silva F. EEG and MEG: relevance to neuroscience. Neuron. 2013;80:1112–28. [DOI] [PubMed]
  • 30.Gao R. Interpreting the electrophysiological power spectrum. J Neurophysiol. 2016;115:628–630. doi: 10.1152/jn.00722.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Voytek B, Knight RT. Dynamic network communication as a unifying neural basis for cognition, development, aging, and disease. Biol Psychiatry Elsevier. 2015;77:1089–1097. doi: 10.1016/j.biopsych.2015.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57:289–300. [Google Scholar]
  • 33.Cornelissen L, Kim S, Purdon PL, Brown EN, Berde CB. Age-dependent electroencephalogram (EEG) patterns during sevoflurane general anesthesia in infants. elife. 2015;4:e06513. [DOI] [PMC free article] [PubMed]
  • 34.Kirch C, Politis DN. TFT-bootstrap: resampling time series in the frequency domain to obtain replicates in the time domain. Ann Stat. 2011;39:1427–1470. doi: 10.1214/10-AOS868. [DOI] [Google Scholar]
  • 35.Benasich AA, Gou Z, Choudhury N, Harris KD. Early cognitive and language skills are linked to resting frontal gamma power across the first 3 years. Behav Brain Res. 2008;195:215–222. doi: 10.1016/j.bbr.2008.08.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N Engl J Med. 2012;367:795–804. doi: 10.1056/NEJMoa1202753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rohrer JD, Nicholas JM, Cash DM, van Swieten J, Dopper E, Jiskoot L, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253–262. doi: 10.1016/S1474-4422(14)70324-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington’s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8:791–801. [DOI] [PMC free article] [PubMed]
  • 39.Wolff JJ, Gu H, Gerig G, Elison JT, Styner M, Botteron KN, et al. Differences in white matter fiber tract development present from 6 to 24 months in infants with autism. Am J Psychiatry. 2012;16:589–600. doi: 10.1176/appi.ajp.2011.11091447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Schumacher EM, Larsson PG, Sinding-Larsen C, Aronsen R, Lindeman R, Skjeldal OH, et al. Automated spectral EEG analyses of premature infants during the first three days of life correlated with developmental outcomes at 24 months. Neonatology. 2013;103:205–212. doi: 10.1159/000345923. [DOI] [PubMed] [Google Scholar]
  • 41.Jones W, Klin A. Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism. Nature. 2013;504:427–31. [DOI] [PMC free article] [PubMed]
  • 42.Hazlett HC, Gu H, Munsell BC, Kim SH, Styner M, Wolff JJ, et al. Early brain development in infants at high risk for autism spectrum disorder. Nature. 2017;542:348-351. [DOI] [PMC free article] [PubMed]
  • 43.Shen MD, Kim SH, McKinstry RC, Gu H, Hazlett HC, Nordahl CW, et al. Increased extra-axial cerebrospinal fluid in high-risk infants who later develop autism. Biol. Psychiatry. 2017;82:186-193. [DOI] [PMC free article] [PubMed]
  • 44.Tager-Flusberg H. Risk factors associated with language in autism spectrum disorder: clues to underlying mechanisms. J Speech Lang Hear Res. 2016;59:143-54. [DOI] [PMC free article] [PubMed]
  • 45.van Driel J, Knapen T, van Es DM, Cohen MX. Interregional alpha-band synchrony supports temporal cross-modal integration. NeuroImage. 2014;101:404–415. doi: 10.1016/j.neuroimage.2014.07.022. [DOI] [PubMed] [Google Scholar]
  • 46.Coon WG, Gunduz A, Brunner P, Ritaccio AL, Pesaran B, Schalk G. Oscillatory phase modulates the timing of neuronal activations and resulting behavior. NeuroImage. 2016;133:294–301. doi: 10.1016/j.neuroimage.2016.02.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wöstmann M, Lim S-J, Obleser J. The human neural alpha response to speech is a proxy of attentional control. Cereb Cortex. 2017;27:3307–3317. doi: 10.1093/cercor/bhx074. [DOI] [PubMed] [Google Scholar]
  • 48.Wojtecki L, Elben S, Vesper J, Schnitzler A. The rhythm of the executive gate of speech: subthalamic low-frequency oscillations increase during verbal generation. Eur J Neurosci. 2017;45:1200–1211. doi: 10.1111/ejn.13429. [DOI] [PubMed] [Google Scholar]
  • 49.Keehn B, Wagner JB, Tager-Flusberg H, Nelson CA. Functional connectivity in the first year of life in infants at-risk for autism: a preliminary near-infrared spectroscopy study. Front Hum Neurosci. 2013;7:444. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Journal of Neurodevelopmental Disorders are provided here courtesy of BMC

RESOURCES